Nanobiosensor-based diagnostic tools in viral infections: Special emphasis on Covid-19.

Ranjita Misra, Sarbari Acharya, Nehru Sushmitha
Author Information
  1. Ranjita Misra: Centre for Molecular and Nanomedical Sciences, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India. ORCID
  2. Sarbari Acharya: Department of Life Science, School of Applied Sciences, Kalinga Institute of Industrial Technology, Bhubaneswar, Odisha, India.
  3. Nehru Sushmitha: Centre for Molecular and Nanomedical Sciences, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.

Abstract

The rapid propagation of novel human coronavirus 2019 and its emergence as a pandemic raising morbidity calls for taking more appropriate measures for rapid improvement of present diagnostic techniques which are time-consuming, labour-intensive and non-portable. In this scenario, biosensors can be considered as a means to outmatch customary techniques and deliver point-of-care diagnostics for many diseases in a much better way owing to their speed, cost-effectiveness, accuracy, sensitivity and selectivity. Besides this, these biosensors have been aptly used to detect a wide spectrum of viruses thus facilitating timely delivery of correct therapy. The present review is an attempt to analyse such different kinds of biosensors that have been implemented for virus detection. Recently, the field of nanotechnology has given a great push to diagnostic techniques by the development of smart and miniaturised nanobiosensors which have enhanced the diagnostic procedure and taken it to a new level. The portability, hardiness and affordability of nanobiosensor make them an apt diagnostic agent for different kinds of viruses including SARS-CoV-2. The role of such novel nanobiosensors in the diagnosis of SARS-CoV-2 has also been addressed comprehensively in the present review. Along with this, the challenges and future position of developing such ultrasensitive nanobiosensors which should be taken into consideration before declaring these nano-weapons as the ideal futuristic gold standard of diagnosis has also been accounted for here.

Keywords

References

  1. Commun Biol. 2021 Jan 15;4(1):70 [PMID: 33452375]
  2. Sens Actuators B Chem. 2019 Oct 1;296:126608 [PMID: 32288255]
  3. Nat Biotechnol. 2020 Jul;38(7):870-874 [PMID: 32300245]
  4. J Pharm Anal. 2020 Apr;10(2):102-108 [PMID: 32282863]
  5. Sci Rep. 2018 Jun 26;8(1):9700 [PMID: 29946074]
  6. J Med Virol. 2020 Sep;92(9):1518-1524 [PMID: 32104917]
  7. Nat Nanotechnol. 2020 Aug;15(8):618-621 [PMID: 32728083]
  8. Mol Cell Probes. 2020 Dec;54:101662 [PMID: 32911064]
  9. Heliyon. 2020 May 27;6(5):e04048 [PMID: 32490248]
  10. J Infect. 2020 Nov;81(5):681-697 [PMID: 32882315]
  11. Biosens Bioelectron. 2012 Jan 15;31(1):439-44 [PMID: 22143073]
  12. Mol Cell Probes. 2020 Oct;53:101636 [PMID: 32634550]
  13. Infect Disord Drug Targets. 2015;15(1):20-31 [PMID: 25910510]
  14. Biosens Bioelectron. 2017 Jun 15;92:349-356 [PMID: 27836599]
  15. J Med Virol. 2020 Jun;92(6):595-601 [PMID: 32100877]
  16. ACS Nano. 2020 May 26;14(5):5268-5277 [PMID: 32281785]
  17. ACS Nano. 2020 Jul 28;14(7):7783-7807 [PMID: 32551559]
  18. Mikrochim Acta. 2019 Mar 7;186(4):224 [PMID: 30847572]
  19. Sci Rep. 2014 Feb 28;4:4116 [PMID: 24576941]
  20. Adv Exp Med Biol. 1988;241:149-64 [PMID: 3265584]
  21. Drug Discov Today. 2010 Oct;15(19-20):842-50 [PMID: 20727417]
  22. Sci Total Environ. 2021 Feb 1;754:142363 [PMID: 33254928]
  23. Front Public Health. 2020 Sep 15;8:567184 [PMID: 33042956]
  24. Clin Chem. 2020 Jul 1;66(7):975-977 [PMID: 32315390]
  25. Anal Biochem. 2018 Sep 15;557:151-155 [PMID: 29908157]
  26. Expert Rev Mol Diagn. 2014 Mar;14(2):225-44 [PMID: 24524681]
  27. ACS Nano. 2020 Apr 28;14(4):5135-5142 [PMID: 32293168]
  28. Theranostics. 2018 Feb 15;8(7):1985-2017 [PMID: 29556369]
  29. Biosens Bioelectron. 2014 May 15;55:278-84 [PMID: 24389391]
  30. Rev Med Virol. 2022 Mar;32(2):e2267 [PMID: 34164867]
  31. Lancet. 2017 Nov 4;390(10107):2099-2109 [PMID: 28647173]
  32. Sensors (Basel). 2019 Jun 09;19(11): [PMID: 31181820]
  33. Oligonucleotides. 2008 Dec;18(4):321-7 [PMID: 18928329]
  34. Sensors (Basel). 2009;9(9):7266-86 [PMID: 22423206]
  35. Biosensors (Basel). 2019 May 21;9(2): [PMID: 31117262]
  36. Virusdisease. 2020 Dec;31(4):441-449 [PMID: 32905186]
  37. Front Chem. 2014 Aug 27;2:63 [PMID: 25221775]
  38. 3 Biotech. 2020 Sep;10(9):385 [PMID: 32818132]
  39. Anal Chim Acta. 2019 Feb 7;1048:31-41 [PMID: 30598155]
  40. Biosens Bioelectron. 2018 Feb 15;100:85-88 [PMID: 28865242]
  41. Biosens Bioelectron. 2020 Oct 15;166:112437 [PMID: 32692666]
  42. Chem Soc Rev. 2012 Mar 21;41(6):2323-43 [PMID: 22170510]
  43. Adv Exp Med Biol. 2014;807:33-58 [PMID: 24619617]
  44. Future Virol. 2019 Jan;14(1):39-49 [PMID: 31933674]
  45. Talanta. 2021 Feb 1;223(Pt 1):121704 [PMID: 33303154]
  46. Clin Vaccine Immunol. 2008 Jan;15(1):159-63 [PMID: 18003814]
  47. Anal Chim Acta. 2016 Jan 15;903:131-41 [PMID: 26709306]
  48. Nat Microbiol. 2020 Apr;5(4):536-544 [PMID: 32123347]
  49. Int J Pharm. 2014 Nov 20;475(1-2):372-84 [PMID: 25178825]
  50. J Basic Microbiol. 2018 Jan;58(1):3-16 [PMID: 29131357]
  51. Chem Sci. 2016 Jun 1;7(6):3892-3899 [PMID: 30155033]
  52. J Virol. 2019 Oct 15;93(21): [PMID: 31413134]
  53. Trends Analyt Chem. 2017 Dec;97:445-457 [PMID: 32287543]
  54. Biotechnol Appl Biochem. 2017 Sep;64(5):735-744 [PMID: 27506960]
  55. ACS Biomater Sci Eng. 2018 Jul 9;4(7):2237-2275 [PMID: 33435097]
  56. Bioessays. 2019 Oct;41(10):e1900049 [PMID: 31441081]
  57. Sensors (Basel). 2020 Dec 04;20(23): [PMID: 33291722]
  58. Nanomaterials (Basel). 2020 May 31;10(6): [PMID: 32486364]
  59. Infect Drug Resist. 2020 Aug 03;13:2657-2665 [PMID: 32801804]
  60. JAMA. 2020 May 12;323(18):1824-1836 [PMID: 32282022]
  61. Nanomedicine. 2017 Feb;13(2):549-557 [PMID: 27558351]
  62. JAMA. 2020 May 12;323(18):1843-1844 [PMID: 32159775]
  63. Talanta Open. 2020 Dec;2:100007 [PMID: 34913046]
  64. Cytokine Growth Factor Rev. 2019 Apr;46:1-9 [PMID: 30954374]
  65. Anal Chem. 2009 Sep 1;81(17):7226-34 [PMID: 19663392]
  66. Nanomedicine (Lond). 2009 Jul;4(5):519-30 [PMID: 19572818]
  67. J Med Virol. 2020 Apr;92(4):408-417 [PMID: 31944312]
  68. J Mol Diagn. 2020 Jun;22(6):729-735 [PMID: 32276051]
  69. Biosens Bioelectron. 2019 May 15;133:24-31 [PMID: 30903938]

MeSH Term

COVID-19
Humans
Nanotechnology
Pandemics
SARS-CoV-2
Virus Diseases

Word Cloud

Created with Highcharts 10.0.0diagnosticbiosensorsnanobiosensorspresenttechniquesrapidnovelvirusesreviewdifferentkindsvirusnanotechnologytakenSARS-CoV-2diagnosisalsoCovid-19propagationhumancoronavirus2019emergencepandemicraisingmorbiditycallstakingappropriatemeasuresimprovementtime-consuminglabour-intensivenon-portablescenariocanconsideredmeansoutmatchcustomarydeliverpoint-of-carediagnosticsmanydiseasesmuchbetterwayowingspeedcost-effectivenessaccuracysensitivityselectivityBesidesaptlyuseddetectwidespectrumthusfacilitatingtimelydeliverycorrecttherapyattemptanalyseimplementeddetectionRecentlyfieldgivengreatpushdevelopmentsmartminiaturisedenhancedprocedurenewlevelportabilityhardinessaffordabilitynanobiosensormakeaptagentincludingroleaddressedcomprehensivelyAlongchallengesfuturepositiondevelopingultrasensitiveconsiderationdeclaringnano-weaponsidealfuturisticgoldstandardaccountedhereNanobiosensor-basedtoolsviralinfections:Specialemphasis

Similar Articles

Cited By